Medtronic

LookDeep Health Expands Executive Team with Director of Nursing and VP of Sales

Retrieved on: 
Wednesday, January 24, 2024

OAKLAND, Calif., Jan. 24, 2024 /PRNewswire/ -- LookDeep Health, a pioneer in transforming hospital care with advanced computer vision and AI technology (VisionAI) for virtual sitting, virtual nursing, and virtual medicine, welcomes Tiffany Wyatt, RN BSN, as Director of Nursing and Kerry Armstrong as VP of Sales.

Key Points: 
  • "Tiffany brings a wealth of clinical knowledge and a deep understanding of nursing workflows, crucial for the seamless integration of our AI technology in enhancing patient care.
  • As Director of Nursing, Wyatt oversees the clinical and operational aspects of LookDeep, helping hospitals enhance how they care for patients.
  • Most recently she served as the Director of Clinical Operations for Optimize Health, a remote patient monitoring solution for healthcare providers.
  • As VP of Sales, Armstrong leads LookDeep's sales strategy, driving revenue growth by identifying market opportunities, building and managing a high-performing sales team and fostering client relationships as the company scales.

Global Surgical Robots Market Report 2024 - Projected at USD 7.3 Billion by 2030: Integration of AI & High Demand for Minimally Invasive Surgeries Propel North America to the Forefront

Retrieved on: 
Wednesday, January 24, 2024

Major players Surgical Robots Market include: Stryker Corporation, Medrobotics, Smith & Nephew, TransEnterix Surgical, Inc., Renishaw plc., Intuitive Surgical, Medtronic, THINK Surgical, Inc., Zimmer Biomet, Asensus Surgical, Siemens Healthineers, CMR Surgical, Johnson & Johnson, Renishaw Plc.

Key Points: 
  • Major players Surgical Robots Market include: Stryker Corporation, Medrobotics, Smith & Nephew, TransEnterix Surgical, Inc., Renishaw plc., Intuitive Surgical, Medtronic, THINK Surgical, Inc., Zimmer Biomet, Asensus Surgical, Siemens Healthineers, CMR Surgical, Johnson & Johnson, Renishaw Plc.
  • The use of medical robotic systems has become widespread in the fields of gynaecology and cosmetology, particularly for minimally invasive surgeries.
  • The demand for these computer-assisted surgical systems is substantial, being utilized in open surgeries, laparoscopic procedures, and flexible endoscopic procedures.
  • One key trend in the Surgical Robots Market is the integration of artificial intelligence (AI) and machine learning (ML) technologies into surgical robotic systems.

GREENBROOK TMS ANNOUNCES DIRECTOR APPOINTMENT

Retrieved on: 
Tuesday, January 23, 2024

TORONTO, Jan. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has appointed Ms. Juliana Elstad to the Company's board of directors as an independent director, effective immediately.

Key Points: 
  • TORONTO, Jan. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has appointed Ms. Juliana Elstad to the Company's board of directors as an independent director, effective immediately.
  • Ms. Elstad has also been appointed to the Company's Governance and Nominating Committee.
  • Juliana Elstad is a CEO, entrepreneur, and advisor with over 20 years of experience bringing medical innovation to patients and delivering success in small startup to multi-billion-dollar environments.
  • She has a proven track record of creating, growing, and leading medical technology organizations with a focus on building dynamic cultures and mentoring high-potential leaders.

Julie Andrews Begins as New Chief Financial Officer at Orthofix

Retrieved on: 
Tuesday, January 16, 2024

(NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Julie Andrews has officially stepped into the role of Chief Financial Officer (CFO).

Key Points: 
  • (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Julie Andrews has officially stepped into the role of Chief Financial Officer (CFO).
  • A seasoned executive, Ms. Andrews previously served as CFO for Smart Wires Technology, a global transmission grid technology company focused on enabling the transition to renewable energy.
  • View the full release here: https://www.businesswire.com/news/home/20240116327144/en/
    “I am excited to welcome Julie to the Orthofix team,” said Massimo Calafiore, President and Chief Executive Officer of Orthofix.
  • “I am excited to work with the talented finance and leadership teams as we look for opportunities to improve our performance while accelerating our business.”

Dr. Ghassan Kassab Joins Anuncia Medical's Board, Elevating Future Product Innovation

Retrieved on: 
Tuesday, January 16, 2024

In this role, Dr. Ghassan will provide guidance and support for the continued commercialization of the ReFlow™ Mini Flusher Device and future innovation to significantly improve patient access and care.

Key Points: 
  • In this role, Dr. Ghassan will provide guidance and support for the continued commercialization of the ReFlow™ Mini Flusher Device and future innovation to significantly improve patient access and care.
  • Dr. Ghassan joins an active, expert group of industry leaders committed to helping Anuncia redefine clinical approaches to cerebrospinal fluid dysfunctions, including hydrocephalus.
  • Dr. Kassab is a successful serial entrepreneur who brings decades of academic and industry experience to Anuncia.
  • We are thrilled that Dr. Kassab has joined our Board to help drive these future innovations," stated Elsa Chi Abruzzo, CEO of Anuncia.

Endologix Announces that Scott Ward Joins Board of Directors

Retrieved on: 
Tuesday, January 9, 2024

Endologix LLC , a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, is pleased to announce that Scott Ward has been appointed to the Endologix Board of Directors.

Key Points: 
  • Endologix LLC , a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, is pleased to announce that Scott Ward has been appointed to the Endologix Board of Directors.
  • Scott Ward was most recently the CEO and Chairman of the Board of Cardiovascular Systems.
  • "We are delighted to announce Scott Ward as the newest member of the Endologix Board of Directors," expressed Matt Thompson, MD, President, and CEO of Endologix.
  • Mr. Ward expressed his enthusiasm about joining the Endologix Board, stating, “I am honored to be appointed to the Endologix Board of Directors.

VANTEDGE MEDICAL APPOINTS BRIGHAM BRANDON AS CHIEF OPERATIONS OFFICER

Retrieved on: 
Friday, January 12, 2024

SAN JOSE, Calif., Jan. 12, 2024 /PRNewswire/ -- Vantedge Medical ("Vantedge"), proven partner to medical device OEM customers in complex precision machining, sophisticated sheet metal manufacturing and assembly and portfolio company of Aterian Investment Partners ("Aterian"), has appointed Brigham Brandon as Chief Operations Officer ("COO").

Key Points: 
  • SAN JOSE, Calif., Jan. 12, 2024 /PRNewswire/ -- Vantedge Medical ("Vantedge"), proven partner to medical device OEM customers in complex precision machining, sophisticated sheet metal manufacturing and assembly and portfolio company of Aterian Investment Partners ("Aterian"), has appointed Brigham Brandon as Chief Operations Officer ("COO").
  • Brigham Brandon brings more than 20 years of experience in operations and supply chain to Vantedge as COO.
  • Most recently at Viant Medical, he led operations for the Advanced Metals Solutions business, which included 7 factories and over 1500 full-time employees.
  • Brigham holds a BA in Philosophy from Wake Forest University and served as an Officer in the U.S. Army.

FDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology

Retrieved on: 
Monday, January 8, 2024

DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its Percept™ RC Deep Brain Stimulation (DBS) system. The rechargeable neurostimulator is the latest innovation in the Medtronic Percept™ family, which includes the Percept™ PC neurostimulator, BrainSense™ technology†, and SenSight™ directional leads. The Percept™ family is the only sensing-enabled DBS system on the market, allowing the physician to personalize treatment for patients with movement disorders such as Parkinson's disease, essential tremor, and dystonia* as well as epilepsy. Over 11 million people in the U.S. are living with movement disorders1-2 and approximately 3.4 million with epilepsy3.

Key Points: 
  • DUBLIN, Jan. 8, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its Percept™ RC Deep Brain Stimulation (DBS) system.
  • The rechargeable neurostimulator is the latest innovation in the Medtronic Percept™ family, which includes the Percept™ PC neurostimulator, BrainSense™ technology†, and SenSight™ directional leads.
  • Percept™ RC is available immediately throughout the U.S., as well as via CE Mark approval in Europe and availability in Japan.
  • For further information on the Percept™ neurostimulators with exclusive BrainSense™ technology, visit our website here .

OKAMI MEDICAL APPOINTS RHONDA ROBB AS PRESIDENT AND CHIEF EXECUTIVE OFFICER

Retrieved on: 
Monday, January 8, 2024

ALISO VIEJO, Calif., Jan. 8, 2024 /PRNewswire/ -- Okami Medical Inc., a medical device company focused on developing innovative solutions that address key unmet clinical needs in peripheral vascular intervention, today announced the appointment of Rhonda Robb as President and Chief Executive Officer.

Key Points: 
  • ALISO VIEJO, Calif., Jan. 8, 2024 /PRNewswire/ -- Okami Medical Inc., a medical device company focused on developing innovative solutions that address key unmet clinical needs in peripheral vascular intervention, today announced the appointment of Rhonda Robb as President and Chief Executive Officer.
  • Rhonda is a proven medical device executive with more than 25 years of leadership and commercial experience.
  • She most recently served as Chief Operating Officer at Cardiovascular Systems, Inc., a leader in the treatment of peripheral and coronary artery disease.
  • "Rhonda brings a proven track record and a wealth of experience to the company," said Bob Rosenbluth, PhD, Co-Founder and Chairman of the Board of Okami Medical.

Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook

Retrieved on: 
Monday, January 8, 2024

Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced preliminary unaudited results for the fourth quarter and full year 2023.

Key Points: 
  • Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced preliminary unaudited results for the fourth quarter and full year 2023.
  • The Company also issued its preliminary 2024 outlook, reflecting an increased focus on driving sustained procedural volume growth ahead of key FDA milestones while reducing cost structure, optimizing capital structure, and accelerating the path to profitability.
  • “We believe procedure volume growth of 30% in 2023 substantiates the significant underlying demand for the Allurion Program, particularly as the efficacy of our offerings continues to be validated by patient results,” said Dr. Shantanu Gaur, CEO of Allurion.
  • I am enthusiastic about our growth catalysts in 2024 and beyond, as we continue to enhance outcomes for patients and create value for our shareholders."